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A recently proposed mechanism of protection for haemoglobin C (HbC; b6GluRLys) links an abnormal display of PfEMP1, an
antigen involved in malaria pathogenesis, on the surface of HbC infected erythrocytes together with the observation of
reduced cytoadhesion of parasitized erythrocytes and impaired rosetting in vitro. We investigated the impact of this
hypothesis on the development of acquired immunity against Plasmodium falciparum variant surface antigens (VSA) encoding
PfEMP1 in HbC in comparison with HbA and HbS carriers of Burkina Faso. We measured: i) total IgG against a single VSA, A4U,
and against a panel of VSA from severe malaria cases in human sera from urban and rural areas of Burkina Faso of different
haemoglobin genotypes (CC, AC, AS, SC, SS); ii) total IgG against recombinant proteins of P. falciparum asexual sporozoite,
blood stage antigens, and parasite schizont extract; iii) total IgG against tetanus toxoid. Results showed that the reported
abnormal cell-surface display of PfEMP1 on HbC infected erythrocytes observed in vitro is not associated to lower anti- PfEMP1
response in vivo. Higher immune response against the VSA panel and malaria antigens were observed in all adaptive
genotypes containing at least one allelic variant HbC or HbS in the low transmission urban area whereas no differences were
detected in the high transmission rural area. In both contexts the response against tetanus toxoid was not influenced by the b-
globin genotype. These findings suggest that both HbC and HbS affect the early development of naturally acquired immunity
against malaria. The enhanced immune reactivity in both HbC and HbS carriers supports the hypothesis that the protection
against malaria of these adaptive genotypes might be at least partially mediated by acquired immunity against malaria.
Citation: Verra F, Simpore J, Warimwe GM, Tetteh KK, Howard T, et al (2007) Haemoglobin C and S Role in Acquired Immunity against Plasmodium
falciparum Malaria. PLoS ONE 2(10): e978. doi:10.1371/journal.pone.0000978
INTRODUCTION
Red blood cell disorders including haemoglobin variants and
thalassaemias provide with their unusually high prevalence and
distribution in malaria endemic areas [1–3] the most compelling
evidence of genetic factors controlling the susceptibility to any
infectious disease in humans. Conclusive evidence exists on the
protective role of Haemoglobin C (HbC; b6GluRLys) against
clinical Plasmodium falciparum malaria [4–6]. Recently, an abnormal
display of PfEMP1, an antigen involved in malaria pathogenesis,
was reported [7,8] on HbAC and HbCC infected erythrocytes that
showed reduced cytoadhesion and impaired rosetting in vitro. On
this basis it has been proposed that HbC protection might be
attributed to the reduced PfEMP1-mediated adherence of
parasitized erythrocytes in the microvasculature. Given the
reported observations, it could be hypothesized that HbC carriers
may develop an altered immune response to PfEMP1. Intriguing-
ly, an enhanced immune recognition of variant surface antigens
(VSA) was initially observed in HbAS individuals by Marsh et al.,
[9] and further demonstrated in a study showing that the presence
of HbAS genotype was associated with enhanced recognition of
two randomly selected clinical isolates amongst Gabonese children
[10]. A cohort study in Kenya lends further support to the
hypothesis of an accelerated acquisition of immunity against mild
clinical malaria in HbAS children ,10 years [11].
The coexistence of HbC and HbS in a hyperendemic malaria
context such as Burkina Faso provided a unique opportunity to
explore this question in a comparative approach. In the present
study, we compared the humoral response to PfEMP1 in individuals
belonging to the Mossi ethnic group carrying different b-globin
genotypes (AA, AC, CC, AS, SC, SS) living in urban and rural areas
of Burkina Faso, West Africa by measuring: i) total IgG against
a single VSA (variant surface antigen), A4U, and against a panel of
VSA from severe malaria cases; ii) total IgG against recombinant
proteins of P. falciparum sporozoite (CSP), blood stage (AMA1, EBA-
175, MSP-119, MSP-2, MSP-3) antigens, parasite schizont extract,
and iii) total IgG against a non malaria antigen, tetanus toxoid.
MATERIALS AND METHODS
Study population
Healthy individuals belonging to the Mossi ethnic group of
Burkina Faso were recruited after oral informed consent was
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obtained during the dry seasons 2005/2006 at the ‘‘Centre
Medical Saint Camille’’ of the capital city Ouagadougou, and in
the villages nearby (Donsin, Kuiti, Nagbagre’) of the Kadiogo
district, as described in Table 1, within a survey of haemoglobi-
nopathies approved by the Ethics Committee of the Saint Camille
Medical Center according to the guidelines of the Ministry of
Health of Burkina Faso. Haemoglobin genotype was determined
by cellulose acetate electrophoresis (Helena). Parasite genomic
DNA was extracted using QIAamp DNA Mini Kit (Qiagen).
Plasmodium falciparum genotyping of glurp was carried out according
to a standard protocol [12] to evaluate parasite positivity assessed
by PCR at the time of sera collection.
Antibody Assays
Antibody responses against the parasite infected-erythrocyte
surface antigens were tested using the method with modifications
of Williams et al. [13] on 85 urban and 85 rural individuals
including all haemoglobin genotypes which were processed in
a single assay against i) a reference isolate A4U, derived by
sequential selection for binding to the monoclonal antibody BC6,
which is specific to the expressed A4U var gene, resulting in
a population of infected erythrocytes expressing predominantly
one specific PfEMP1 variant on their surface, A4U PfEMP1 [14]
and ii) a composite isolate (CI) derived by pooling a panel of wild
isolates obtained from children presenting to the wards of Kilifi
district hospital in Kenya with malaria at high parasitemia (T.H
and T.N.W unpublished data).
FACS analysis Mature trophozoite stage parasitized RBC
(pRBC) at between 3–5% parasitaemia were thawed from frozen
culture using saline solutions according to a gradient from 12% to
0.9% in a suspension at 50% haematocrit with buffer (0.5% BSA/
PBS). 1 ml of serum was pipetted into separate wells of a 96-well
U-bottomed plate (Falcon, Becton Dickinson, USA) to which was
added 11.5 ml of the infected pRBC cell suspension in 0.5%BSA/
PBS and 10 mg/ml of ethidium bromide. The mixture was
incubated at room temperature for 30 min, following which the
cells were washed three times with 0.5%BSA/PBS, centrifuging at
1000 rpm for 3 min per wash. The cells were then re-suspended in
50 ml 0.5%BSA/PBS containing a 1:50 dilution of sheep anti-
human c chain (FITC) fluorescein isothiocyanate-conjugated
antibody (The Binding Site) was added to each well. A further
incubation at room temperature in darkness, for 30 min was
carried out, after which, following a further series of washes, at
least 1000 pRBC were counted on an EPIC/XL flow cytometer
(Coulter, UK). The Mean Fluorescence Intensity (MFI) was
defined as the difference between the geometric mean of the
fluorescence emitted by trophozoite pRBC and the geometric
mean of the fluorescence emitted by the non pRBC. Non-specific
recognition as measured by European negative controls was
subtracted by the MFI of tested individuals.
ELISA analysis Enzyme linked immunosorbant assays
(ELISA) were performed according to well established protocols
[15,16]. Assays were performed in duplicate for each serum
sample (N=387) against the circumsporozoite protein (CSP) of P.
falciparum (NANP16 CDC reagent gift from Patrick Corran,
LSHTM, London, UK) and several blood stage antigens: full
length 3D7 allele of AMA-1 (gift from David Lanar, Walter Reed
Army Institute for Research, Washington, DC), Wellcome allele of
MSP-119 (gift from Patrick Corran, LSHTM, with permission of
Tony Holder, London, UK), Dd2 allele of MSP-2 (gift from David
Cavanagh, Institute of Immunology and Infection Research,
Edinburgh, UK), 3D7 allele of MSP-3 (gift from Spencer Polley,
LSHTM, London, UK), Camp allele F2 domain of EBA-175
region II (gift from Chetan Chitnis, ICGEB, New Delhi, India),
and the Wellcome strain parasite schizont extract (gift from David
Walliker, Institute of Cell, Animal and Population Biology,
Edinburgh prepared by Lindsay Stewart, LSTHM, London,
UK). When antigens were conjugated to GST or MBP, the optical
density (OD) of GST or MBP for each sample was subtracted from
that of the antigen to obtain the final OD. All assays were
performed in Dynex Immunolon 4HBX ELISA plates (Dynex
Technologies Inc). Wells were coated with 50 ng for all blood
stage antigens (1 mg for CSP and PSE) in 100 ml of carbonate
buffer (15 mM Na2CO3, 35 mM NAHCO3, pH 9.3), and
incubated overnight at 4uC before washing four times in PBS/
Tween (Phosphate Buffered Saline/0.05% Tween 20). The plates
were then incubated in 200 ml/well of blocking buffer (1%
skimmed milk in PBS/Tween) for 5 hours at room temperature.
Antigen-coated wells were washed and incubated overnight at 4uC
with test sera (1/500 dilution) at 100 ml/well. Unbound antibody
was washed off, and 100 ml of secondary antibody (HRP-
conjugated rabbit anti-human IgG, Dako Ltd.) diluted to 1/
5000 in blocking buffer was added into each well and incubated
for 3 hours at room temperature before detection with O-
phenylenediamine (OPD, Sigma). The reaction was stopped with
25 ml/well of 2M H2SO4. The absorbance was read at OD 492nm
using the SPECTRAFluor program, (XFLUOR4 Version: V 4.11)
and analysed using Excel (Microsoft). The coefficient of variation
Table 1. Study samples of Mossi ethnic group of Burkina Faso.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Geographic Origin Period of blood collection Haemoglobin genotype
Rural samples (EIR.100) AA AC CC AS SC SS Total
Donsin Dry season (April 2006 ) 46 (16.0) 16 (11.7) 4 (9.0) 2 (8.5) 2 (13.0) - 70
Kuiti Dry season (April 2006 ) 20 (10.7) 11 (10.2) 8 (9.2) 5 (10.2) 2 (9.0) 2 (9.5) 48
Nagbagre´ Dry season (April 2006 ) - - 2+1* (15.0) - - - 3
Urban samples (EIR:1-10)
Ouagadougou Dry season (January–May 2005) - 80 (30.0)** 10 (27.4)*** 40 (29.5)1 8 (19.2)11 2 (8.0) 140
Ouagadougou Dry season (January–May 2006) 86 (29.0)& 26 (24.5)&& 3 8 (32.5)&&& 3 (18.3) - 126
Total 152 133 28 55 15 4 387
Individuals are indicated for each genotype and origin; age is given in brackets.
*recruited in December 2004; **age available for 50 subjects; ***age available only for 5 subjects; 1age available only for 29 subjects; 11age available only for 6 subjects;
&age available only for 63 subjects; &&age available only for 22 subjects; &&&age available only for 6 subjects.
doi:10.1371/journal.pone.0000978.t001..
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(CV) between duplicate wells was calculated in Excel (Microsoft)
using the formula below to ensure accuracy:
CV~standard deviation=mean OD of duplicate wells (%)
The mean OD of each duplicate was used as the final read-out.
The cut-off for positive samples was determined by taking the
mean plus 3 standard deviations of twenty (20) non-immune sera
for all antigens. All samples were tested for each antigen and its
conjugated molecule in a single assay to avoid any daily variation.
OD values were log-transformed for normal distribution and
differences in means of antibody levels and MFIs according to the
different genotypes were tested by Kruskal-Wallis and pairwise
comparisons by Two Sample T test. For all tests, P values of less
than 0.05 were considered significant. Logistic regression was used
to examine the relationship between antibody levels and the
chosen variables: Hb genotype, age categories (1/9, 10/max
years), gender and parasite positivity assessed by PCR. All analyses
were carried out in STATA (StataCorp.1999, Release (9.2)).
RESULTS
Serological reactivities to P. falciparum VSA
No differences in the Mean Fluorescence Intensity (MFI)
according to the haemoglobin genotype were detected when
looking at urban and rural samples all together. Further
comparisons were carried out separately with the urban and the
rural samples due to the different EIR (entomological inoculation
rate) and mean age of the two subsets whose characteristics are
described in Table 1. No differences were observed in the MFI of
the different haemoglobin genotypes against the A4U isolate in
both subsets, whereas we found significant differences in the urban
sera (P= 0.04 amongst all adaptive genotypes and HbAA; P= 0.02
between HbAA and HbAC; P= 0.03 between HbAA and HbAS)
when testing the panel of composite isolates (CI) of severe malaria
VSA from Kilifi (Figure 1).
Serological reactivities to P. falciparum antigens and
parasite schizont extract
Prevalence and levels of antibodies tested against all antigens was
consistently higher in the villages due to higher exposure to malaria
of the rural subset despite the relatively younger age (Table 2,
Table 3). Within the urban samples higher levels of total IgG
amongst genotypes containing at least one adaptive haemoglobin
allele compared to HbAA were observed for most of the P. falciparum
antigens tested by ELISA, with some degree of statistical significance
as measured by Kruskal-Wallis test and pairwise T-test (Table 2,
Figure 2). Remarkably, the same observation of higher levels of IgG
in all genotypes including HbC and HbS alleles was confirmed by
CSP and schizont extract, both considered markers of exposure
(Table 2, Figure 2). However, significantly higher levels of total IgG
against P. falciparum antigens were observed in the rural samples only
against EBA-175 in the overall comparisons, and against AMA1 in
the comparisons between HbAA versus HbAC, and HbAA versus
HbCC (Table 2). Differences observed in the primary analysis were
tested by logistic regression including Hb genotype, age categories
(1/9, 10/max years), gender and parasite status confirming the role
of adaptive genotypes for most of the tested antigens (Table 3).
Finally, a non malaria antigen, tetanus toxoid, was tested revealing
no differences in any of the subsets (data not shown).
Figure 1. Mean Fluorescence Intensity (MFI) of total IgG against Plasmodium falciparum A4 Ultra parasite isolate (A4U) and a panel of
Composite Isolates (CI) expressing VSA in urban samples of Mossi from Ouagadougou, Burkina Faso according to the different haemoglobin
genotypes.
doi:10.1371/journal.pone.0000978.g001
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DISCUSSION
Despite substantial evidence of protection against clinical malaria
given by the haemoglobin variants HbC and HbS, the precise
mechanism(s) are still under debate. A recently proposed
mechanism suggested that the protection conferred by HbC may
be attributed to the reduction of cytoadherence and impaired
rosetting observed in relation to the altered display of PfEMP1 on
HbCC erythrocytes [7,8] which raises the question of whether this
would affect VSA recognition, and ultimately the immune
reactivity against VSA. Taking on from this hypothesis we
anticipated a difference in antibody levels of HbCC homozygous,
possibly a reduction due to their impaired VSA expression. Also,
an ‘‘immunological hypothesis’’ initially proposed for HbS has
been supported by a number of studies in various epidemiological
contexts although the functional mechanisms involved in the
enhanced acquisition of natural immunity observed in HbAS
Table 2. Total IgG means of log transformed OD values against several blood stage antigens (AMA1, EBA-175, MSP-119, MSP-2,
MSP-3), circumsporozoite protein (CSP), and parasite schizont extract (PSE) of Plasmodium falciparum in urban and rural sera of
Burkina Faso.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Antigen Prevalence Pairwise comparisons
Urban samples (N= 266) AA vs AC AC vs CC AA vs CC AA vs AS Overall
AMA1 78% P=0.001 NS P= 0.01 P = 0.001 P = 0.0001
EBA-175 73% P=0.04 NS P= 0.01 P = 0.03 P = 0.02
MSP-119 67% NS P= 0.03 P= 0.01 P = 0.01 NS (P = 0.06)
MSP-2 64% P=0.001 NS P= 0.03 P = 0.004 P = 0.0001
MSP-3 70% NS NS NS P= 0.02 NS
CSP 65% P=0.05 NS P= 0.03 P = 0.001 P = 0.03
PSE 74% P=0.01 NS P= 0.04 P = 0.01 P = 0.05
Rural samples (N = 121)
AMA1 90% P=0.03 NS P= 0.03 NS NS
EBA-175 76% NS (P = 0.07) NS NS NS (P = 0.06) P = 0.05
MSP-119 70% NS NS NS NS NS
MSP-2 82% NS NS NS NS NS
MSP-3 77% NS NS NS NS NS
CSP 68% NS NS NS NS NS
PSE 78% NS NS NS NS NS
doi:10.1371/journal.pone.0000978.t002..
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Table 3. Geometric means and 95% Confidence intervals in brackets of log transformed OD values against several blood stage
antigens (AMA1, EBA-175, MSP-119, MSP-2, MSP-3), circumsporozoite protein (CSP), and parasite schizont extract (PSE) of
Plasmodium falciparum in urban and rural sera of Burkina Faso.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Antigen AA AC AS CC SC SS
Urban Samples (N = 266)
AMA1 2.90 (2.78–3.03) 3.14 (3.06–3.22) 3.20 (3.10–3.31) 3.27 (3.16–3.38) 3.23 (3.05–3.41) 3.40 (3.35–3.46)
EBA-175 2.75 (2.70–2.81) 2.82 (2.78–2.87) 2.84 (2.77–2.92) 2.91 (2.79–3.04) 2.82 (2.65–2.99) 3.15 (3.05–3.25)
MSP-119 2.45 (2.34–2.58) 2.56 (2.46–2.66) 2.67 (2.54–2.81) 2.83 (2.60–3.08) 2.60 (2.38–2.85) 2.81 (2.58–3.05)
MSP-2 2.97 (2.84–3.10) 3.19 (3.13–3.26) 3.22 (3.12–3.32) 3.26 (3.15–3.38) 3.38 (3.36–3.40) 3.40 (3.35–3.46)
MSP-3 2.44 (2.35–2.53) 2.50 (2.43–2.58) 2.60 (2.50–2.71) 2.55 (2.37–2.74) 2.66 (2.38–2.97) 2.52 (2.45–2.61)
CSP 2.74 (2.69–2.80) 2.82 (2.77–2.87) 2.88 (2.82–2.95) 2.88 (2.75–3.01) 2.85 (2.70–3.01) __
PSE 2.50 (2.44–2.57) 2.60 (2.56–2.65) 2.64 (2.56–2.72) 2.66 (2.55–2.77) 2.63 (2.46–2.82) 2.74 (1.26–3.95)
Rural samples (N = 121)
AMA1 3.12 (3.04–3.20) 3.27 (3.18–3.36) 3.09 (2.54–3.76) 3.31 (3.23–3.40) 3.06 (2.59–3.62) 3.39*
EBA-175 2.82 (2.74–2.90) 2.94 (2.85–3.03) 3.03 (2.76–3.34) 2.95 (2.81–3.08) 2.70 (2.28–3.20) 3.16*
MSP-119 2.82 (2.60–3.06) 2.54 (1.31–4.92) 1.92* __ __ __
MSP-2 2.82 (2.70–2.94) 2.87 (2.75–2.99) 2.82 (2.37–3.35) 2.89 (2.57–3.25) 2.88 (2.41–3.45) 3.24*
MSP-3 2.57 (2.48–2.67) 2.71 (2.58–2.84) 2.52 (2.11–3.01) 2.69 (2.41–3.01) 2.86 (1.03–5.97) 2.55*
CSP 2.80 (2.75–2.85) 2.82 (2.77–2.86) 2.88 (2.82–2.94) 2.76 (2.73–2.79) 2.77 (2.68–2.85) __
PSE 2.55 (2.46–2.65) 2.61 (2.49–2.74) 2.72 (2.55–2.90) 2.59 (2.48–2.70) 2.56 (0.83–7.89) 2.62*
*single individual
doi:10.1371/journal.pone.0000978.t003..
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remain elusive [9,10]. Therefore, we investigated haemoglobin
phenotype-specific immune reactivity to a composite isolate
expressing a wide range of P. falciparum VSAs in subjects resident
in two different malaria endemic contexts of Burkina Faso. Results
showed that the reported abnormal cell-surface display of PfEMP1
on HbC infected erythrocytes observed in vitro is not associated to
lower anti- PfEMP1 humoral response in vivo. In fact, higher
immune response against the P. falciparum VSA panel and several
antigens were observed in all adaptive genotypes containing at
least one allelic variant HbC or HbS in the low transmission urban
area (Figure 1). Interestingly, cross-reactive antibody responses, i.e.
those directed against erythrocyte surface expressed parasite
antigens from heterologous parasite isolates are an important
component of acquired immunity against malaria [17–19].
However, no differences were detected in the high transmission
rural areas. Significantly higher levels of antibodies at several P.
falciparum antigens were also observed in the same urban samples
(Table 2, Table 3, Figure 2). These differences were not explained
by age or parasite status at that time point as confounders for most
of the antigens examined (Table 4), rather reflected the cumulative
effect of a life long exposure to P. falciparum malaria in the presence
of a protective factor such as HbC and/or HbS. In both contexts
the response against tetanus toxoid was not influenced by the b-
globin genotype. Thus, these findings suggest that both HbC and
HbS could promote the early development of naturally acquired
immunity against malaria. The enhanced immune reactivity in
both HbC and HbS carriers supports the hypothesis that the
protection against malaria of these adaptive genotypes might be at
least partially mediated by acquired immunity against malaria.
We believe that the discrepancy between results from urban and
rural settings could be the consequence of saturated immunity in
high transmission contexts. These observations emphasize the
need, when studying candidates of genetic resistance/susceptibility
to malaria and their underlying hypothesized mechanisms, to take
into full account the epidemiological context as a potential
confounder.
Although this study can not conclusively validate any of the
different functional mechanisms proposed to explain the pro-
tection of haemoglobin variants, a consistently enhanced immune
reactivity in both HbC and HbS adaptive genotypes suggests the
idea of a convergence in terms of their impact on the acquisition of
immunity against malaria. It has been already shown that the
model initially proposed for explaining G6PD protection, by
enhanced phagocytosis of ring- parasitized altered erythrocytes,
fits well also in the case of HbS and b-thalassemia [20]. Thus, it
may be possible that this mechanism may also be extended to the
Figure 2. Means levels of total IgG against several blood stage antigens of Plasmodium falciparum (AMA1, EBA-175, MSP-119, MSP-2, MSP-3)
and parasite schizont extract in urban samples of Mossi from Ouagadougou, Burkina Faso according to the different haemoglobin genotypes.
The horizontal lines in each box correspond to the median values, the lower edge of each box is the 25% ile and the upper edge is the 75% ile. The
whiskers represent the range of the data beyond these percentiles, excluding outliers represented by dots.
doi:10.1371/journal.pone.0000978.g002
Table 4. Logistic regression analysis of antibody levels against
all Plasmodium falciparum tested antigens
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Antigen Variable
Hb genotype Age Gender Parasite +
AMA1 P= 0.001 NS NS NS
EBA-175 NS NS NS NS
MSP-119 NS (P = 0.06) NS NS NS
MSP-2 P = 0.003 NS NS NS
MSP-3 NS (P = 0.08) NS NS NS
CSP P= 0.004 NS NS NS
PSE P = 0.01 P = 0.01 NS NS
A4 MFI NS NS NS NS
CI MFI P = 0.05 NS NS NS
doi:10.1371/journal.pone.0000978.t004..
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case of HbC. Further investigation in the rural areas so far
examined, focusing on young children, especially below five years,
is undergoing to unravel the modulation exerted by HbC (and
HbS) on the onset of naturally acquired immunity to malaria.
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